Achieve Life Sciences, Inc. Diluted Shares Outstanding (Weighted Average)
Achieve Life Sciences, Inc. (ACHV) reported Diluted Shares Outstanding (Weighted Average) of 93.51 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 93.51M shares, a 169.60% increase year-over-year.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 53.38M shares, a 53.90% increase year-over-year.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 53.81M shares, a 55.85% increase year-over-year.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 51.02M shares, a 48.50% increase year-over-year.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 43.59M shares, a 35.93% increase from fiscal 2024.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 32.07M shares, a 61.75% increase from fiscal 2023.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 19.83M shares, a 87.18% increase from fiscal 2022.
- Achieve Life Sciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 10.59M shares, a 30.46% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 93.51M shares 10-Q · filed 2026-08-11 | 73.56M shares 10-Q · filed 2026-08-11 | 66.90M shares derived: average of 3 quarters · filed 2026-08-11 | 62.93M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | 53.38M shares 10-Q · filed 2026-05-12 | 53.60M shares derived: average of 2 quarters · filed 2026-05-12 | 52.74M shares derived: average of 3 quarters · filed 2026-05-12 | 48.22M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | 53.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 52.41M shares derived: average of 2 quarters · filed 2026-03-24 | 46.50M shares derived: average of 3 quarters · filed 2026-08-11 | 43.59M shares 10-K · filed 2026-03-24 | |
| 2025-09-30 | 51.02M shares 10-Q · filed 2025-11-06 | 42.85M shares derived: average of 2 quarters · filed 2026-08-11 | 40.19M shares 10-Q · filed 2025-11-06 | 38.73M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | 34.69M shares 10-Q · filed 2026-08-11 | 34.69M shares 10-Q · filed 2026-08-11 | 34.63M shares derived: average of 3 quarters · filed 2026-08-11 | 34.56M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | 34.69M shares 10-Q · filed 2026-05-12 | 34.61M shares derived: average of 2 quarters · filed 2026-05-12 | 34.52M shares derived: average of 3 quarters · filed 2026-05-12 | 34.47M shares derived: average of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | 34.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 34.44M shares derived: average of 2 quarters · filed 2026-03-24 | 34.40M shares derived: average of 3 quarters · filed 2026-03-24 | 32.07M shares 10-K · filed 2026-03-24 | |
| 2024-09-30 | 34.36M shares 10-Q · filed 2025-11-06 | 34.34M shares derived: average of 2 quarters · filed 2025-11-06 | 31.25M shares 10-Q · filed 2025-11-06 | 28.73M shares derived: average of 4 quarters · filed 2026-03-24 | |
| 2024-06-30 | 34.32M shares 10-Q · filed 2025-08-07 | 29.68M shares 10-Q · filed 2025-08-07 | 26.85M shares derived: average of 3 quarters · filed 2026-03-24 | 25.42M shares derived: average of 4 quarters · filed 2026-03-24 | |
| 2024-03-31 | 25.05M shares 10-Q · filed 2025-05-13 | 23.11M shares derived: average of 2 quarters · filed 2026-03-24 | 22.45M shares derived: average of 3 quarters · filed 2026-03-24 | 21.60M shares derived: average of 4 quarters · filed 2026-03-24 | |
| 2023-12-31 | 21.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 21.15M shares derived: average of 2 quarters · filed 2026-03-24 | 20.45M shares derived: average of 3 quarters · filed 2026-03-24 | 19.83M shares 10-K · filed 2026-03-24 | 19.83M shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 21.13M shares 10-Q · filed 2024-11-07 | 20.09M shares derived: average of 2 quarters · filed 2024-11-07 | 19.38M shares 10-Q · filed 2024-11-07 | 17.92M shares derived: average of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | 19.05M shares 10-Q · filed 2024-08-13 | 18.49M shares 10-Q · filed 2024-08-13 | 16.85M shares derived: average of 3 quarters · filed 2025-03-11 | 15.06M shares derived: average of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | 17.92M shares 10-Q · filed 2024-05-09 | 15.74M shares derived: average of 2 quarters · filed 2025-03-11 | 13.73M shares derived: average of 3 quarters · filed 2025-03-11 | 12.71M shares derived: average of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | 13.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 11.63M shares derived: average of 2 quarters · filed 2025-03-11 | 10.97M shares derived: average of 3 quarters · filed 2025-03-11 | 10.59M shares 10-K · filed 2025-03-11 | |
| 2022-09-30 | 9.69M shares 10-Q · filed 2023-11-09 | 9.67M shares derived: average of 2 quarters · filed 2023-11-09 | 9.60M shares 10-Q · filed 2023-11-09 | 9.57M shares derived: average of 4 quarters · filed 2024-03-28 | |
| 2022-06-30 | 9.65M shares 10-Q · filed 2023-08-14 | 9.55M shares 10-Q · filed 2023-08-14 | 9.52M shares derived: average of 3 quarters · filed 2024-03-28 | 9.51M shares derived: average of 4 quarters · filed 2024-03-28 | |
| 2022-03-31 | 9.46M shares 10-Q · filed 2023-05-09 | 9.46M shares derived: average of 2 quarters · filed 2024-03-28 | 9.46M shares derived: average of 3 quarters · filed 2024-03-28 | 8.94M shares derived: average of 4 quarters · filed 2024-03-28 | |
| 2021-12-31 | 9.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 9.46M shares derived: average of 2 quarters · filed 2024-03-28 | 8.77M shares derived: average of 3 quarters · filed 2024-03-28 | 8.12M shares 10-K · filed 2024-03-28 | |
| 2021-09-30 | 9.45M shares 10-Q · filed 2022-11-14 | 8.42M shares derived: average of 2 quarters · filed 2022-11-14 | 7.67M shares 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 7.39M shares 10-Q · filed 2022-08-11 | 6.76M shares 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | 2.72M shares 10-K · filed 2023-03-16 | ||||
| 2012-09-30 | 14.62M shares 10-Q · filed 2012-11-08 | 13.14M shares 10-Q · filed 2012-11-08 | |||
| 2011-09-30 | 10.04M shares 10-Q · filed 2012-11-08 | 9.88M shares derived: average of 2 quarters · filed 2012-11-08 | 9.72M shares 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | 9.72M shares 10-Q · filed 2011-08-05 | 9.72M shares 10-Q · filed 2011-08-05 | |||
| 2010-09-30 | 6.45M shares 10-Q · filed 2011-11-03 | 6.49M shares derived: average of 2 quarters · filed 2011-11-03 | 6.40M shares 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | 6.53M shares 10-Q · filed 2011-08-05 | 6.37M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |